|
KMID : 0363120230360010106
|
|
Korean Journal of Pain
2023 Volume.36 No. 1 p.106 ~ p.112
|
|
|
Risk analysis of musculoskeletal pain intervention using corticosteroid during COVID-19 pandemic: a cohort study
|
|
Mohamad Azwan Aziz
Mohamed Nahar Azmi
|
|
|
Abstract
|
|
|
Background: Most international bodies recommended against musculoskeletal steroid injection during the COVID-19 pandemic, fearing that the immunosuppressive effects of the steroid could worsen COVID-19 infection, thus prolonging the suffering of patients with severe musculoskeletal disease. The authors’ aim is to analyze the risk of COVID-19 infection after musculoskeletal injections.
Methods: This is a retrospective study of patients who visited a sports medicine clinic and received musculoskeletal steroid injections between January 1, 2020 and February 28, 2021. The collected data was compared with the national COVID-19 registry to identify positive COVID-19 patients. The patients were only considered positive for COVID-19 following corticosteroid injection within 3 months after injection.
Results: Out of 502 steroid injections; 79.7% (n = 400) received a single injection in one day, 19.1% (n = 96) received steroid injections at 2 sites in one day, and 1.2% (n = 6) received steroid injections at 3 sites in one day. Using the Fisher?s exact test, there was no statistically significant association of COVID-19 infection between the steroid group and control group (relative risk, 1.44; 95% confidence interval, 0.9?23.1, P = 0.654). Only one patient contracted mild COVID-19 with no post COVID complications.
Conclusions: The authors recommend the use of musculoskeletal steroid injections in clinically indicated situation without having increased risk of COVID-19.
|
|
|
KEYWORD
|
|
|
COVID-19, Injections, Malaysia, Musculoskeletal Pain, Pain Management, Pandemics, Risk Factors, Steroids
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
   
|
|